Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of ATG5 as Aserum Marker of Autophgy in Psoriasis Vulgaris Patients

NCT05279638 is registered in ClinicalTrials.gov with Sohag University as lead sponsor.

NCT NCT05279638
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05279638 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of ATG5 as Aserum Marker of Autophgy in Psoriasis Vulgaris Patients
Lead sponsor
Sohag University
Phase
Observational
Overall status
Unknown status
Start date
February 1, 2022
Completion date
January 1, 2024
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autophagy, psoriasis vulgaris